Utama › Artritis Juvenil › New York
Kajian klinikal Artritis Juvenil di New York
5 kajian untuk Artritis Juvenil sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Col Uni Med Center New York Presby, New York
Mengambil pesertaFasa 1
Umur 2 hingga 17 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06751238Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Boston Childrens Health Physicians /ID# 253437, Valhalla
Mengambil pesertaFasa 3
Umur 1 hingga 17 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Columbia University Medical Center /ID# 262587, New York
- Boston Childrens Health Physicians /ID# 258061, Valhalla
Mengambil pesertaFasa 3
Umur 5 hingga 17 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Albany Medical College, Albany
- Cohen Children's Medical Center of New York, Lake Success
- Hospital for Special Surgery, New York
- dan 3 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 21 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT02418442Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
- NYU Langone Health, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2026 · NCT07138898Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.